Mette Mejlby Hansen

Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection

Christian Lodberg Hvas, Simon Mark Dahl Baunwall, Søren Peter Jørgensen et al. · Gastroenterology · 2019 · 357 citations · Full text

Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial

Simon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 112 citations

Dysbiosis, Antimicrobial Susceptibility, Placebo-controlled Trial +7

Faecal microbiota transplantation: establishment of a clinical application framework

Simon Mark Dahl Baunwall, Mette Mejlby Hansen, Christian Erikstrup et al. · European Journal of Gastroenterology & Hepatology · 2017 · 45 citations

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study

Mette Julsgaard, Daniel C. Baumgart, Simon Mark Dahl Baunwall et al. · Alimentary Pharmacology & Therapeutics · 2021 · 42 citations · Full text

Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy

Mette Julsgaard, Jantien W. Wieringa, Simon Mark Dahl Baunwall et al. · Clinical Gastroenterology and Hepatology · 2024 · 23 citations · Full text